Tag | Content |
---|
EnhancerAtlas ID | HS134-09799 |
Organism | Homo sapiens |
Tissue/cell | Mesendoderm |
Coordinate | chr11:33933860-33934650 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
LBX2 | MA0699.1 | chr11:33934227-33934237 | GCTAATTGGC | - | 6.02 | MEOX1 | MA0661.1 | chr11:33934195-33934205 | GCTAATTAAC | + | 6.02 | ZNF263 | MA0528.1 | chr11:33934123-33934144 | TTCTCTTCCCCTGGCTCCTCT | - | 6.07 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_09380 | chr11:33931760-33936195 | CD14 | SE_13375 | chr11:33932922-33934965 | CD34_Primary_RO01536 | SE_14120 | chr11:33933145-33934586 | CD34_Primary_RO01549 | SE_33500 | chr11:33930714-33936676 | H2171 | SE_68369 | chr11:33920144-33976413 | TC32 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH11I033912 | chr11 | 33933713 | 33934903 |
|
Enhancer Sequence | TGTGAATTAG GGAGTTAAGG ATCAAGATGA CGTGTAGAGC AGCGATTTTT GTTAGAATGC 60 AAACTAAGCT GTGCTAGACT TAGTCTCAAA AAGAAATGTA AGTCTGAGGT CTGAGTTTGG 120 CCTCTCCCTA ACGGGCGGAG ACTGTGGCTC TCCACCCCAT GCACGGTCCG GAAGCAGGCA 180 AGCAAGTTTG CCCTGGGCTT TGTTCTACAT TTTAGTGGGG CAGGGCCCAC TGCAGCCAAG 240 TTATTAAGCA CTAGGTCTCT CACTTCTCTT CCCCTGGCTC CTCTCTGCTG GGCCTCCTGC 300 CCTACCATCA AGGCAGCTGT TGTTGTTTTG TAGAGGCTAA TTAACTCCAC ACTGCATGAA 360 GCCAGACGCT AATTGGCCCA CTCACTTAAT CAACCTTAAT GTCTCTCTTC TGGTGGACAC 420 GGCTGCTGCT TTTTGTTCCC CTGATCATCA ACAAACGTGG TTCCAGGCGA ATGGCAGCAA 480 CAGCCTCTGG TGGTAACAGC CCTCAGCCTG TCACCTACCA CGGGAAATAC TGAGGCTCAT 540 TTTGACACCT CAGCTCAGTG GACAGGCCCT CAAGTTCATG ATCACCGAAG CATCTTGAAA 600 CCTGAGCTTA TTGCTGCTCT TCCAAACATT GCATGATGAT ATGAGTCATC AGATGGTTGG 660 TTACTCAAGA GAATTGGCCT CATCTCTGTC TGTTGCTGAC ACATAGTTAA GACTATAACA 720 TCTAACTTAT ACAGCTACCT TTTGCTGAGT GTTTTTTTTT TTTCTGTAGC ACTGTGTCGG 780 GGCCTTTCCA 790
|